Selected article for: "genetic background and high risk"
Author: Funakoshi, Shunsuke; Yoshida, Yoshinori
Title: Recent progress of iPSC technology in cardiac diseases
  • Cord-id: p8f716gl
  • Document date: 2021_10_17
    • ID: p8f716gl
    Snippet: It has been nearly 15 years since the discovery of human-induced pluripotent stem cells (iPSCs). During this time, differentiation methods to targeted cells have dramatically improved, and many types of cells in the human body can be currently generated at high efficiency. In the cardiovascular field, the ability to generate human cardiomyocytes in vitro with the same genetic background as patients has provided a great opportunity to investigate human cardiovascular diseases at the cellular leve
    Document: It has been nearly 15 years since the discovery of human-induced pluripotent stem cells (iPSCs). During this time, differentiation methods to targeted cells have dramatically improved, and many types of cells in the human body can be currently generated at high efficiency. In the cardiovascular field, the ability to generate human cardiomyocytes in vitro with the same genetic background as patients has provided a great opportunity to investigate human cardiovascular diseases at the cellular level to clarify the molecular mechanisms underlying the diseases and discover potential therapeutics. Additionally, iPSC-derived cardiomyocytes have provided a powerful platform to study drug-induced cardiotoxicity and identify patients at high risk for the cardiotoxicity; thus, accelerating personalized precision medicine. Moreover, iPSC-derived cardiomyocytes can be sources for cardiac cell therapy. Here, we review these achievements and discuss potential improvements for the future application of iPSC technology in cardiovascular diseases.

    Search related documents:
    Co phrase search for related documents
    • acute phase and low percentage: 1, 2
    • acute phase and low specificity: 1, 2, 3
    • acute phase and machine learning: 1, 2, 3, 4, 5, 6, 7, 8
    • low percentage and machine learning: 1, 2, 3, 4, 5
    • low specificity and machine learning: 1, 2, 3, 4, 5, 6, 7, 8
    • low specificity and machine learning artificial intelligence: 1